A clinical evaluation of MK-0787/MK-0791 for long-term administration in urological infections

A clinical evaluation of MK-0787/MK-0791 for long-term administration in urological infections

MK-0787 (Imipenem)/MK-0791 (Cilastatin sodium), a new compound of Thienamycin, was administered in treatment of 35 patients (36 cases) with chronic complicated UTI or for prevention of serious infections with much complicated factors. The patients were principally treated at a daily dose of 1 g for...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 32(1986), 9 vom: 15. Sept., Seite 1387-408
1. Verfasser: Suzuki, K (VerfasserIn)
Weitere Verfasser: Takanashi, K, Naide, Y, Fujita, T, Ogawa, T, Hirabayashi, S, Tamai, H, Yanaoka, M, Ishiguro, K, Asano, H
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1986
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Journal Article Anti-Bacterial Agents Cyclopropanes Thienamycins Cilastatin 141A6AMN38 Imipenem 71OTZ9ZE0A